AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimibrod M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Biozinik Healthcare Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimibrod M 1mg/500mg Tablet

Diabexe Duo 1mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabexe Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended.

Uses of Glimibrod M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimibrod M 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and timeframe. Ingest the entire tablet without chewing, crushing, or breaking it. Glimibrod M 1mg/500mg tablets should be taken with a meal.

Common Side effects of Glimibrod M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimibrod M 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimibrod M 1mg/500mg tablets should be taken with meals.

How Glimibrod M 1mg/500mg Tablet works:

Glimepiride and Metformin, combined as Glimibrod M 1mg/500mg tablets, offer dual action against high blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin. Metformin, a biguanide, reduces liver glucose output, slows intestinal glucose uptake, and enhances insulin responsiveness in tissues.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption and Glimibrod M 1mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimibrod M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks before prescribing. Consult your doctor for advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimibrod M 1mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimibrod M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glimibrod M 1mg/500mg tablet use. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimibrod M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Individuals with mild to moderate hepatic dysfunction should typically commence treatment with a reduced Glimibrod M 1mg/500mg tablet dosage; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Glimibrod M 1mg/500mg Tablet :

Should you forget a Glimibrod M 1mg/500mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimibrod M 1mg/500mg Tablet

LabelValue
Potential for Dependence None.
Medication Category Medication for diabetes

FAQs on Glimibrod M 1mg/500mg Tablet

Always keep this medication in its original, tightly sealed container or packaging. Follow the storage instructions provided on the label or packaging. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and others.
Glimibrod M 1mg/500mg Tablets may cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Symptoms can include muscle aches or weakness, vertigo, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms appear, discontinue Glimibrod M 1mg/500mg Tablet use and seek immediate medical attention.
Glimepiride and Metformin, combined as Glimibrod M 1mg/500mg tablets, manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with a healthy diet and regular physical activity. Glimepiride's action involves stimulating insulin secretion from the pancreas, thus reducing blood glucose. Metformin reduces hepatic glucose production and increases insulin sensitivity. This dual-agent therapy is unsuitable for type 1 DM.
Glimibrod M 1mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Indeed, prolonged Glimibrod M 1mg/500mg Tablet consumption can lead to Vitamin B12 deficiency. This medication impedes Vitamin B12 absorption within the gastrointestinal tract. Left unaddressed, this deficiency might result in anemia, neurological complications, paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive alterations, and ataxia. Prophylactic annual Vitamin B12 supplementation is recommended by some studies to mitigate these risks.
Indeed, Glimibrod M 1mg/500mg Tablets may induce hypoglycemia. Low blood sugar symptoms encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. These symptoms are more prevalent with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Glimibrod M 1mg/500mg tablets and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). Alcohol consumption also raises the likelihood of lactic acidosis.
Glimibrod M 1mg/500mg Tab...
45
MRP 55
18% off